-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, IZGzcK/iquUW5ToJlG8K77kY5qPJ8n8aGqXkd6JFYa/x8Lf5ywMO5sgHDbgCoDz/ qKJ444mZ0XktRS3K97DxIg== 0000927946-02-000141.txt : 20021209 0000927946-02-000141.hdr.sgml : 20021209 20021209164009 ACCESSION NUMBER: 0000927946-02-000141 CONFORMED SUBMISSION TYPE: 3 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20021127 FILED AS OF DATE: 20021209 SUBJECT COMPANY: COMPANY DATA: COMPANY CONFORMED NAME: PHARMAKINETICS LABORATORIES INC CENTRAL INDEX KEY: 0000351506 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-TESTING LABORATORIES [8734] IRS NUMBER: 521067519 STATE OF INCORPORATION: MD FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: 3 SEC ACT: 1934 Act SEC FILE NUMBER: 000-11580 FILM NUMBER: 02852540 BUSINESS ADDRESS: STREET 1: 302 W FAYETTE ST CITY: BALTIMORE STATE: MD ZIP: 21201 BUSINESS PHONE: 4103854500 MAIL ADDRESS: STREET 1: 302 W FAYETTE STREET CITY: BALTIMORE STATE: MD ZIP: 21201 REPORTING-OWNER: COMPANY DATA: COMPANY CONFORMED NAME: BIOANALYTICAL SYSTEMS INC CENTRAL INDEX KEY: 0000720154 STANDARD INDUSTRIAL CLASSIFICATION: LABORATORY APPARATUS & FURNITURE [3821] RELATIONSHIP: OWNER IRS NUMBER: 351345024 STATE OF INCORPORATION: IN FISCAL YEAR END: 0930 FILING VALUES: FORM TYPE: 3 BUSINESS ADDRESS: STREET 1: 2701 KENT AVE CITY: WEST LAFAYETT STATE: IN ZIP: 47906-1382 BUSINESS PHONE: 3174634527 MAIL ADDRESS: STREET 1: 2701 KENT AVENUE CITY: WEST LAFAYETTE STATE: IN ZIP: 47906-1382 3 1 form3bas.htm BIOANALYTICAL SYSTEMS, INC. FORM 3 Form 3 - Bioanalytical Systems, Inc.
FORM 3
OMB APPROVAL

OMB NUMBER:  3235-0104

Expires:  January 1, 2005









U.S. SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility
Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940

1.  Name and Address of Reporting Person*

    Bioanalytical Systems, Inc.

    (Last)                   (First)                     (Middle)         




    2701 Kent Avenue



    Lafayette                      Indiana                      47906      
       (City)                      (State)                         (Zip)     
2.  Date of Event
     Requiring Statement
     (Month/Day/Year)

        11/27/02



3.  IRS or Social
     Security Number of
     Reporting Person
     (Voluntary)


4.  Issuer Name and Ticker or Trading Symbol

     PharmaKinetics Laboratories, Inc.
5.  Relationship of Reporting Person to Issuer
         (Check all applicable)

            Director                X  10% Owner

            Officer                       Other
            (give title below)        (Specify below)



6.  Nature of Indirect
     Beneficial Ownership
     (Instr. 5)


7.  Individual or Joint/Group
     Filing (Check Applicable
     Line)

  X   Form filed by One
        Reporting Person

      Form filed by More than
        One Reporting Person
Table I — Non-Derivative Securities Beneficially Owned
1.  Title of Security
     (Instr. 4)











2.  Amount of Securities
     Beneficially Owned
     (Instr. 4)










3.  Ownership
     Form: Direct (D)
     or Indirect (I)
     (Instr. 5)









4.  Nature of Indirect Beneficial Ownership
     (Instr. 5)











Reminder:  Report on a separate line for each class of securities beneficially owned directly or indirectly.
(Print or Type Responses)
(Over)
SEC 1473 (3/91)

FORM 3 (continued)             Table II — Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1.  Title of Derivative Security
     (Instr. 4)
2.  Date of Exercisable
     and Expiration Date
     (Month/Day/Year)

    Date           Expiration
Exercisable          Date

3.  Title and Amount of Securities
     Underlying Derivative Security 
     (Instr.4)

     Title                     Amount or
                                  Number
                                  of Shares
4.  Conversion
     or Exercise
     Price of
     Derivative
     Security
5.  Ownership
    Form of
    Derivative
    Security:
    Direct (D) or
    Indirect (I)
    (Instr. 5)
6.  Nature of Indirect
     Beneficial Ownership
     (Instr. 5)
Secured Convertible Revolving Note 11/27/02           *** Common Shares           5,835,962 $0.1585 D




























































Explanation of Responses:


  *If form is filed by more than one person, see Instruction 5(b)(v).
 **Intentional misstatements or omissions of facts constitute Federal Criminal Violations.
    See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
               /s/  Peter T. Kissinger
                 ** Signature of Reporting Person
December 6, 2002
        Date
***The Secured Convertible Revolving Note may be converted by Bioanalytical Systems, Inc. ("BAS") into Common Shares of PharmaKinetics Laboratories, Inc. at any time when any balance of principal or interest is outstanding under the Secured Convertible Revolving Note. The entire outstanding balance of principal and interest is due on May 1, 2003, and upon such payment, BAS's right to convert the Secured Convertible Revolving Note into Common Shares of PharmaKinetics Laboratories, Inc. will expire.
Note:  File three copies of this Form, one of which must be manually signed. If space provided is insufficient,
See Instruction 6 for procedure
Page 2
SEC 1473 (10-99)
-----END PRIVACY-ENHANCED MESSAGE-----